| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 8, 2024 | Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering | |
| Mar 11, 2024 | Human Liver Model Global Market Report 2024: Surge in Clinical Trials & Innovative Model Systems to Propel Growth | |
| Oct 19, 2023 | Технологии продления жизни: как развивается 3D-печать органов | Данной публикацией мы начинаем серию материалов, посвященных технологиям продления жизни. В этой статье речь пойдет о регенеративной медицине. Это относительно новое направление в сфере здравоохранения. Она позволяет восстанавливать и замен... |
| Apr 13, 2023 | Fork & Good targets cost parity for cultivated pork: ‘It’s a totally useless exercise to make products nobody can afford’ | In theory, growing meat from animal cells instead of slaughtering billions of sentient creatures and plundering the oceans sounds like a no-brainer: The promise of ‘real’ meat, without the ethical and environmental baggage.
In practice, man... |
| Sep 17, 2021 | Organovo : Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum | SOLANA BEACH, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that the Company’s annual meeting of shareholders, on September 14, 2021, at 9:00 a.m. was convened and adjourned, without any ... |
| Sep 17, 2021 | ORGANOVO : ANNOUNCES ADJOURNMENT OF ANNUAL MEETING OF SHAREHOLDERS DUE TO LACK OF QUORUM (Form 8-K) | ORGANOVO ANNOUNCES ADJOURNMENT OF
ANNUAL MEETING OF SHAREHOLDERS DUE TO LACK OF QUORUM
Solana Beach, CA., September 17, 2021-Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that the Company's annual meeting of shareholders, on Septe... |
| Feb 23, 2021 | Purpose At Work: Modern Meadow's Path To Industry Disruption, Growth And A Sustainable Future | Purpose At Work: Modern Meadow's Path To Industry Disruption, Growth And A Sustainable FuturePHOTO PROVIDED BY Modern Meadow |
| Oct 12, 2018 | Meeting’s nearly fourfold attendance growth highlights cell, gene therapies’ rise | This was a far cry from the first meeting in 2006, when around 350 scientists huddled for warmth against a hostile world. Early gene therapies had ended in disaster, with the deaths of Jesse Gelsinger and others, and federal restrictions we... |
| Apr 12, 2017 | Organovo cofounder and long-time CEO Keith Murphy steps down | The news was somewhat unexpected for investors, triggering a five percent drop in Organovo’s share price. There’s not too much cause for alarm, however, given a new CEO has already been named and Murphy will remain chairman of the board and... |
| Dec 15, 2016 | 8 technologies that will transform healthcare in 2017 and beyond | At this moment in time, healthcare stands on the cusp of a fundamental reset itself and technology may as well lead the way to whatever system we end up with. A new report from PricewaterhouseCooper’s Health Research Institute, Top Health I... |
| Sep 7, 2016 | This is how 3-D bioprinting companies are transforming drug development | Organovo is the leader in 3-D bioprinting at the moment. The publicly traded San Diego company has been selling 3-D liver tissue to pharma companies for about 18 months and is about to expand into kidney tissue. The goal is to support drug ... |
| Jun 8, 2016 | Inside the sci-fi world of growing human tissue and organs in the lab | Inside a North Carolina lab, row upon row of plastic bioreactor bags pulsate gently to the beat of an artificial heart. Within each bag, a lab-forged blood vessel slowly expands, feeding off a primordial cocktail of vitamins and proteins.
T... |
| Sep 30, 2015 | 3D printing outlook balances gains with the regulatory headache of hospitals producing customized devices | Among the considerable challenges ahead are regulatory and ethical hurdles. Stephenson said although the FDA has said it will continue to treat 3D-printed technology as a standard medical device manufacturing process, they have not yet deal... |
| Aug 17, 2015 | Watch out, Organovo: BioBots launching new line of low-cost 3D bioprinters | BioBots is operating on very lean capital — it’s got less than $1 million in equity raised on the books. The startup spun out last year from University of Pennsylvania, developed by a small team of undergraduates. It also was a member of th... |
| Aug 10, 2015 | Five new life sciences startups at Philadelphia accelerator | Freenome
This London-based liquid biopsy startup is establishing a new office in Philly – using next-generation sequencing to diagnose cancers with just 1 milliliter of blood. With the potentially low-cost but accurate liquid biopsy method,... |
| Jun 18, 2015 | Organovo Announces $40M Underwritten Public Offering | San Diego 3-D bioprinting company Organovo Holdings Inc. announced Thursday a $40 million underwritten public offering of its common stock.
The offering includes 9,425,000 shares at a price to the public of $4.25 per share. The company has ... |
| Oct 24, 2014 | Organovo CEO: Closing IPO Window Could Spur More Reverse Mergers | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Shifting perceptions and a cooling IPO market could lead more biotech startups to join a public stock exchange via a reverse merger with a shell company that is already public... |
| Feb 9, 2014 | How NASA Prints Trees | Lynn Rothschild has short brown hair and smiley eyes. She cracks jokes about biology and microscopes with ease. Diana Gentry, her decades-younger Ph.D. student, loves classic video games and vegetarian cooking. She lives near Silicon Valley... |
| Jan 29, 2014 | First mutual fund for 3D printing heralds industry’s mainstreaming | If the other indications weren’t enough, the first mutual fund targeted at 3D printing and technology shows that the industry has now entered the mainstream.
In fact, 3D Printing and Technology Fund head Alan Meckler told VentureBeat that 3... |
| May 27, 2013 | Listening To The Future With A 3D-Printed Ear | The campus of Washington State University in Southeast Washington’s agricultural region looks like a typical land-grant university. The connected mix of art-deco, modern, and post-modern buildings that collectively house the College of Engi... |
| Feb 10, 2013 | 3D bioprinter and “virus traps” take top startup honors at FutureMed pitch contest | As you’d expect at an event called FutureMed, disruption ruled this week’s event, and Saturday’s startup pitch contest was no exception.
Of the 27 companies that participated, the two that wowed the panel of investor judges the most were se... |
| Feb 6, 2013 | The first 3D-printed human stem cells | The shortage of transplantable organs has spawned a fascinating science and market. A liver, for example, is often split among two recipients, while for a cystic fibrosis patient in need of two lungs, it is technically preferable to just sw... |
| Jan 30, 2013 | 3D printing makes its way into cancer research lab with Organovo-OHSU collaboration | “In research we think of cancer as a cell in a dish, but really it’s a collection of cells working in tissue,” he said. “This will allow us to better understand the tumor micro-environment, and to see the many cell types together and the mo... |
| Dec 17, 2012 | Design Software For Organ And Tissue Printing Is On Its Way With Autodesk, Organovo Partnership | Autodesk’s software may be best-known for helping architects design buildings or for prototyping products, but it soon may be applied to designing tissues and organs.
Autodesk and Organovo, a publicly-traded bioprinting company, are partner... |
| Watch out, Organovo: BioBots launching new line of low-cost 3D bioprinters | This September, Philadelphia startup BioBots will roll out a new line of desktop 3D bioprinters — going up against companies like the capital-heavy Organovo.
The company’s developing smaller, easier to use, cheaper 3D tissue printing machin... |
| 3D printing makes its way into cancer research lab with Organovo-OHSU collaboration | 3D printing gets a lot of hype for the things it will someday be able to do, like replicate human organs and create customized prosthetics. But it’s doing some pretty cool things in the meantime, too, like helping researchers create living ... |
| 3D bioprinter and “virus traps” take top startup honors at FutureMed pitch contest | As you’d expect at an event called FutureMed, disruption ruled this week’s event, and Saturday’s startup pitch contest was no exception.
Of the 27 companies that participated, the two that wowed the panel of investor judges the most were se... |
| Meeting’s nearly fourfold attendance growth highlights cell, gene therapies’ rise | The Alliance for Regenerative Medicine’s (ARM’s) annual Cell and Gene Meeting needs a bigger boat. Now in its 13th year, the conference attracted more than 1,200 people to Torrey Pines Mesa in San Diego, from October 3 to 5. Last year it dr... |
| 8 technologies that will transform healthcare in 2017 and beyond | While technology is no silver bullet able to solve all that ails the healthcare industry, it has always been part and parcel of any revolution.
Think of the printing revolution and its influence of the Protestant Reformation that forever cr... |
| This is how 3-D bioprinting companies are transforming drug development | Let’s face it, cells generally like having company, forming communities with other cell types to make complete tissues. However, quite often, researchers isolate cells from their 3-D environments, creating 2-D models that don’t always repli... |
| Organovo cofounder and long-time CEO Keith Murphy steps down | One of San Diego, California’s flagship biotech companies, Organovo Holdings, is poised to get a new CEO, according to a statement released by the company on Wednesday.
Cofounder and long-time Chief Executive Keith Murphy will step down on ... |
| Five new life sciences startups at Philadelphia accelerator | Philadelphia’s University City Science Center’s Port business accelerator just announced it’s fostering some pretty interesting life sciences startups – ranging from cancer diagnostics to 3D bioprinting.
Biobots
In the vein of Organovo, reg... |
| 3D printing outlook balances gains with the regulatory headache of hospitals producing customized devices | The 3D printing market is transforming the medical device industry and has the potential to impact the biotech industry. There’s plenty of excitement about its potential to change the way we think of organ procurement longterm. But in a pre... |
